GB1488995A - Compositions containing anti-androgenic compounds - Google Patents
Compositions containing anti-androgenic compoundsInfo
- Publication number
- GB1488995A GB1488995A GB7644/75A GB764475A GB1488995A GB 1488995 A GB1488995 A GB 1488995A GB 7644/75 A GB7644/75 A GB 7644/75A GB 764475 A GB764475 A GB 764475A GB 1488995 A GB1488995 A GB 1488995A
- Authority
- GB
- United Kingdom
- Prior art keywords
- methylene
- compositions containing
- containing anti
- androgenic compounds
- feb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 239000003098 androgen Substances 0.000 title abstract 2
- 230000002280 anti-androgenic effect Effects 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 238000002347 injection Methods 0.000 abstract 2
- 239000007924 injection Substances 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44617174A | 1974-02-28 | 1974-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1488995A true GB1488995A (en) | 1977-10-19 |
Family
ID=23771577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB7644/75A Expired GB1488995A (en) | 1974-02-28 | 1975-02-24 | Compositions containing anti-androgenic compounds |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4092413A (en, 2012) |
| JP (1) | JPS50129716A (en, 2012) |
| DE (1) | DE2508613A1 (en, 2012) |
| DK (1) | DK50375A (en, 2012) |
| FR (1) | FR2262526B1 (en, 2012) |
| GB (1) | GB1488995A (en, 2012) |
| NL (1) | NL7501563A (en, 2012) |
| SE (1) | SE7501518L (en, 2012) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040077605A1 (en) | 2001-06-20 | 2004-04-22 | Salvati Mark E. | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| US6960474B2 (en) | 2000-06-28 | 2005-11-01 | Bristol-Myers Squibb Company | Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator |
| US7001911B2 (en) | 2000-06-28 | 2006-02-21 | Bristol-Myers Squibb Company | Fused cyclic modulators of nuclear hormone receptor function |
| EP1854798A3 (en) * | 2000-09-19 | 2007-11-28 | Bristol-Myers Squibb Company | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| US6953679B2 (en) | 2000-09-19 | 2005-10-11 | Bristol-Myers Squibb Company | Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof |
| US20040087548A1 (en) | 2001-02-27 | 2004-05-06 | Salvati Mark E. | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| EP1467979B1 (en) * | 2001-12-19 | 2008-08-13 | Bristol-Myers Squibb Company | Fused heterocyclic compounds and analogs thereof modulators of nuclear hormone receptor function |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3380886A (en) * | 1965-04-07 | 1968-04-30 | Upjohn Co | 7alpha-methyl-3beta-hydroxy-5-androstenes |
-
1975
- 1975-02-10 NL NL7501563A patent/NL7501563A/xx not_active Application Discontinuation
- 1975-02-11 SE SE7501518A patent/SE7501518L/xx unknown
- 1975-02-12 DK DK50375*#A patent/DK50375A/da unknown
- 1975-02-24 GB GB7644/75A patent/GB1488995A/en not_active Expired
- 1975-02-26 FR FR7506011A patent/FR2262526B1/fr not_active Expired
- 1975-02-27 DE DE19752508613 patent/DE2508613A1/de not_active Withdrawn
- 1975-02-28 JP JP50024119A patent/JPS50129716A/ja active Pending
-
1977
- 1977-06-23 US US05/809,512 patent/US4092413A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS50129716A (en, 2012) | 1975-10-14 |
| SE7501518L (en, 2012) | 1975-08-29 |
| US4092413A (en) | 1978-05-30 |
| FR2262526A1 (en, 2012) | 1975-09-26 |
| DK50375A (en, 2012) | 1975-11-03 |
| DE2508613A1 (de) | 1975-09-04 |
| FR2262526B1 (en, 2012) | 1978-07-28 |
| NL7501563A (nl) | 1975-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE42692L (en) | Oestrogenic compositions | |
| GB1500374A (en) | Oral pharmaceutical preparation | |
| NZ312303A (en) | Novel nor-pregnanes for inducing hypothalamic effects | |
| GB1488995A (en) | Compositions containing anti-androgenic compounds | |
| HU9503578D0 (en) | Androstane steroids as neurochemical initilators of change in human hypothalamic function and related pharmaceutical compositions and methods | |
| GB1291205A (en) | A novel pregnane derivative, processes for its preparation, and compositions incorporating it | |
| GB1487334A (en) | Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof | |
| HU9503579D0 (en) | Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods | |
| GB1270614A (en) | Stable aqueous steroid phosphate solutions | |
| GB1529607A (en) | Medicinal composition | |
| GB1483650A (en) | Pharmaceutical preparations based on mesterolone | |
| IE34308L (en) | 11ß, 13ß-DIALKYLGONA-1,3,5(10)-TRIEN-3-OL 3-CYCLOALKYL¹ETHERS | |
| GB1474749A (en) | Pharmaceutical preparations based on cyproterone | |
| GB1235768A (en) | 6,7 - methylene - 20 - spiroxanes | |
| GB1465771A (en) | Pharmaceutical composition and use thereofd | |
| GB1326528A (en) | Method of contraception and compositions used therein | |
| GB1363801A (en) | Peptides and their preparation | |
| GB1515017A (en) | 2',3'-dihydroestra-1,3,5(10)-trieno-(16alpha,17alpha-b)furan-17beta-ols | |
| GB1340528A (en) | Psychotropic medicinal composition | |
| MXPA94000705A (es) | Esteroides de estreno como iniciadores neuroquimicos del cambio en la funcion hipotalamica humana ycomposiciones farmaceuticas y metodos relacionados. | |
| IL43236A (en) | 15alpha,16alpha-methylene-19-nor-delta4-pregnene-3,20-diones | |
| GB1291414A (en) | Aerosol composition | |
| GB1294538A (en) | Pharmaceutical compositions | |
| GB1449441A (en) | Agnets for lowering the lipid level in plasma | |
| GB1428347A (en) | 6alpha-, 7alpha-dihydro-3h-cyclopropa-6,7-pregna-4,6-diene- 3,15,20-trione and related compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |